BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 35447718)

  • 1. Microemulsions and Nanoemulsions in Skin Drug Delivery.
    Souto EB; Cano A; Martins-Gomes C; Coutinho TE; Zielińska A; Silva AM
    Bioengineering (Basel); 2022 Apr; 9(4):. PubMed ID: 35447718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fabrication of Alginate-Based O/W Nanoemulsions for Transdermal Drug Delivery of Lidocaine: Influence of the Oil Phase and Surfactant.
    Sarheed O; Dibi M; Ramesh KVRNS; Drechsler M
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33925764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microemulsions: a novel approach to enhanced drug delivery.
    Talegaonkar S; Azeem A; Ahmad FJ; Khar RK; Pathan SA; Khan ZI
    Recent Pat Drug Deliv Formul; 2008; 2(3):238-57. PubMed ID: 19075911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microemulsions as transdermal drug delivery vehicles.
    Kogan A; Garti N
    Adv Colloid Interface Sci; 2006 Nov; 123-126():369-85. PubMed ID: 16843424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oil components modulate the skin delivery of 5-aminolevulinic acid and its ester prodrug from oil-in-water and water-in-oil nanoemulsions.
    Zhang LW; Al-Suwayeh SA; Hung CF; Chen CC; Fang JY
    Int J Nanomedicine; 2011; 6():693-704. PubMed ID: 21556344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrogel-thickened nanoemulsions based on essential oils for topical delivery of psoralen: Permeation and stability studies.
    Barradas TN; Senna JP; Cardoso SA; Nicoli S; Padula C; Santi P; Rossi F; de Holanda E Silva KG; Mansur CRE
    Eur J Pharm Biopharm; 2017 Jul; 116():38-50. PubMed ID: 27867112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential of Non-aqueous Microemulsions to Improve the Delivery of Lipophilic Drugs to the Skin.
    Carvalho VF; de Lemos DP; Vieira CS; Migotto A; Lopes LB
    AAPS PharmSciTech; 2017 Jul; 18(5):1739-1749. PubMed ID: 27757922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation characterization and in vitro drug release of hydrogel-thickened nanoemulsions for topical delivery of 8-methoxypsoralen.
    Barradas TN; Senna JP; Cardoso SA; de Holanda E Silva KG; Elias Mansur CR
    Mater Sci Eng C Mater Biol Appl; 2018 Nov; 92():245-253. PubMed ID: 30184748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microemulsions as a surrogate carrier for dermal drug delivery.
    Azeem A; Khan ZI; Aqil M; Ahmad FJ; Khar RK; Talegaonkar S
    Drug Dev Ind Pharm; 2009 May; 35(5):525-47. PubMed ID: 19016057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microemulsions as potential drug delivery systems: a review.
    Ansari MJ; Kohli K; Dixit N
    PDA J Pharm Sci Technol; 2008; 62(1):66-79. PubMed ID: 18402369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critical appraisal of microemulsions for drug delivery: part II.
    Sapra B; Thatai P; Bhandari S; Sood J; Jindal M; Tiwary AK
    Ther Deliv; 2014 Jan; 5(1):83-94. PubMed ID: 24341819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomedical applications of microemulsion through dermal and transdermal route.
    Shukla T; Upmanyu N; Agrawal M; Saraf S; Saraf S; Alexander A
    Biomed Pharmacother; 2018 Dec; 108():1477-1494. PubMed ID: 30372850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of stable nanoemulsions by ultrasound-assisted two-step emulsification process for topical drug delivery: Effect of oil phase composition and surfactant concentration and loratadine as ripening inhibitor.
    Sarheed O; Shouqair D; Ramesh KVRNS; Khaleel T; Amin M; Boateng J; Drechsler M
    Int J Pharm; 2020 Feb; 576():118952. PubMed ID: 31843549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lecithin microemulsions for the topical administration of ketoprofen: percutaneous adsorption through human skin and in vivo human skin tolerability.
    Paolino D; Ventura CA; Nisticò S; Puglisi G; Fresta M
    Int J Pharm; 2002 Sep; 244(1-2):21-31. PubMed ID: 12204562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Traversing the Skin Barrier with Nano-emulsions.
    Burger C; Shahzad Y; Brummer A; Gerber M; du Plessis J
    Curr Drug Deliv; 2017; 14(4):458-472. PubMed ID: 27557672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nano- and Microemulsions in Biomedicine: From Theory to Practice.
    Nikolaev B; Yakovleva L; Fedorov V; Li H; Gao H; Shevtsov M
    Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microemulsions containing medium-chain glycerides as transdermal delivery systems for hydrophilic and hydrophobic drugs.
    Hosmer J; Reed R; Bentley MV; Nornoo A; Lopes LB
    AAPS PharmSciTech; 2009; 10(2):589-96. PubMed ID: 19440842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microemulsions for topical delivery of estradiol.
    Peltola S; Saarinen-Savolainen P; Kiesvaara J; Suhonen TM; Urtti A
    Int J Pharm; 2003 Mar; 254(2):99-107. PubMed ID: 12623186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal delivery of hydrophobic and hydrophilic local anesthetics from o/w and w/o Brij 97-based microemulsions.
    Junyaprasert VB; Boonme P; Songkro S; Krauel K; Rades T
    J Pharm Pharm Sci; 2007; 10(3):288-98. PubMed ID: 17727792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of microemulsions in dermal and transdermal drug delivery.
    Santos P; Watkinson AC; Hadgraft J; Lane ME
    Skin Pharmacol Physiol; 2008; 21(5):246-59. PubMed ID: 18562799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.